Ivor Royston, CEO & President at Viracta Therapeutics, Inc. (VIRX), sold 26,758 shares at $4.01 ($107K) on 2022-08-26, disclosed to the SEC on 2022-08-29.
Open-market sale of $107k VIRX by CEO & President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.01 | 13,379 | $54K | 50.0% |
| 2 | $4.01 | 13,379 | $54K | 50.0% |
| Total | $4.01 avg | 26,758 | $107K | 100% |
| Filing → |
| VIRX | BUY | 2021-11-15 | $44K | — | Filing → |
| BIOC | BUY | 2017-03-29 | $50K | — | Filing → |
| SNDX | BUY | 2016-03-08 | $1.8M | — | Filing → |